China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development of a Multimodal Prediction Model for Pseudoprogression After Radiotherapy in High-Grade Glioma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134727
Registration Time: 2026/10/20
Type: Observational study
Primary Sponsor: Liuzhou Worker's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348409
Published by HT Digital Content Services with permission from Health Daily Digest....